Kindstar Globalgene Technology, Inc. (HKG:9960)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.460
0.00 (0.00%)
Jul 16, 2025, 4:08 PM HKT
2.82%
Market Cap1.51B
Revenue (ttm)987.09M
Net Income (ttm)-58.09M
Shares Out1.03B
EPS (ttm)-0.06
PE Ration/a
Forward PEn/a
Dividend0.02 (1.63%)
Ex-Dividend DateJun 9, 2025
Volume1,033,500
Average Volume1,096,800
Open1.500
Previous Close1.460
Day's Range1.440 - 1.500
52-Week Range0.930 - 1.520
Beta0.73
RSI62.85
Earnings DateAug 15, 2025

About HKG:9960

Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People’s Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. The company’s lab platforms comprise flow cytometry, cytogenetic, medical genomics, m... [Read more]

Sector Healthcare
Founded 2003
Employees 3,011
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9960
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.